ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Compass Therapeutics, Inc. (CMPX)

NASDAQ

$6.28

$-0.05

(-0.79%)

Compass Therapeutics, Inc. (CMPX) Live Price Chart

Page last updated: 2026-02-14 00:55:00

Key Market Data

Market Cap	$1.12B
Open	$6.53
High	$12.50
Low	$0.77
Previous Close	$6.34
Price Change	$-0.05
Percentage Change	-0.79%
Volume	3M

Compass Therapeutics, Inc. (CMPX) Stock Price Today

Compass Therapeutics, Inc. (CMPX) is currently trading at $6.28 as of 2026-02-14 00:55:00, reflecting a -0.79% move ($-0.05) from the previous close.

In the short term, the stock has returned +1,017.54% over the past four weeks. Over the last 12 months, Compass Therapeutics, Inc. has recorded a +85.80% price change, indicating a strong performance relative to the broader market.

Compass Therapeutics, Inc. (CMPX) 7-Day Stock Price Changes

Over the past seven days, Compass Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $6.50 to the latest recorded price of $6.28, reflecting an intraday change of -0.79%. Daily movements highlight shifts in trading volume (2,509,515), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, CMPX has delivered a +1,017.54% return over the past month and a +85.80% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Compass Therapeutics, Inc. (CMPX)

You can buy and trade CMPX on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for CMPX and Execute Your Trade

Open the trading page, enter CMPX in the search bar, select the amount of CMPX you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Compass Therapeutics, Inc. (CMPX)?

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Compass Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	35
Sector	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Company Website	https://www.compasstherapeutics.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Compass Therapeutics, Inc.?

The latest trading price for Compass Therapeutics, Inc. (Common Stock) is $ 6.28, compared with a previous closing price of $ 6.34. That means the stock has moved -0.79% so far today. Intraday price updates and recent trading activity for CMPX can be tracked on the live chart and quote section on this page.

2.Is Compass Therapeutics, Inc. stock going up or down?

Looking at recent performances, CMPX has returned +1,017.54% over the past month, +130.88% over the last six months and +85.80% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Compass Therapeutics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does CMPX currently sit relative to its 52-week high and low?

In the most recent 52-week period, Compass Therapeutics, Inc. has traded between a low of $ 1.33 and a high of $ 6.88. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether CMPX is currently nearer the top or the bottom of its one-year trading band.

4.How is Compass Therapeutics, Inc. classified by sector and industry?

Compass Therapeutics, Inc. is classified in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. In practice, this means Compass Therapeutics, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing CMPX’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector could influence Compass Therapeutics, Inc.’s performance.

5.Where is Compass Therapeutics, Inc. listed and how large is it by market value?

Compass Therapeutics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 1.12B, the company is classified as a Small-cap stock. Market cap gives a quick sense of Compass Therapeutics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does CMPX's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.37 summarises how much profit Compass Therapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Compass Therapeutics, Inc.'s financial performance over time?

To follow Compass Therapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how CMPX is performing and how the market is responding.

8.When is Compass Therapeutics, Inc. expected to report earnings?

Compass Therapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for CMPX, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Compass Therapeutics, Inc.'s earnings reports?

Compass Therapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether CMPX is meeting, beating or missing expectations.

10.How can I stay informed about Compass Therapeutics, Inc.'s results and guidance?

You can stay up to date on Compass Therapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for CMPX on this page helps you see how new information is being reflected in the stock.

11.Does Compass Therapeutics, Inc. pay a regular cash dividend to its shareholders?

Compass Therapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor CMPX's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for CMPX?

Based on the latest earnings data, CMPX has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Compass Therapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Compass Therapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Compass Therapeutics, Inc.?

Compass Therapeutics, Inc. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is CMPX valued in terms of P/E ratio and EPS?

Compass Therapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.37. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Compass Therapeutics, Inc.'s earnings. Comparing CMPX's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Compass Therapeutics, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

CHR

Innovation Beverage Group Limited

IBG

Lumentum Holdings Inc.

LITE

Top Gainers

Browse today's leading gainers in the US stock market

Digital Brands Group, Inc.

DBGI

Founder Group Limited

FGL

JIADE LIMITED

JDZG

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

CMPX-to-USD Calculator

Amount

CMPX

USD

1 CMPX = 6.28 USD